• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

癌症中的多药耐药性:ATP 依赖性转运蛋白的作用

Multidrug resistance in cancer: role of ATP-dependent transporters.

作者信息

Gottesman Michael M, Fojo Tito, Bates Susan E

机构信息

Laboratory of Cell Biology and Cancer Therapeutics Branch, The Center for Cancer Research, National Institutes of Health, Bethesda, Maryland 20892, USA.

出版信息

Nat Rev Cancer. 2002 Jan;2(1):48-58. doi: 10.1038/nrc706.

DOI:10.1038/nrc706
PMID:11902585
Abstract

Chemotherapeutics are the most effective treatment for metastatic tumours. However, the ability of cancer cells to become simultaneously resistant to different drugs--a trait known as multidrug resistance--remains a significant impediment to successful chemotherapy. Three decades of multidrug-resistance research have identified a myriad of ways in which cancer cells can elude chemotherapy, and it has become apparent that resistance exists against every effective drug, even our newest agents. Therefore, the ability to predict and circumvent drug resistance is likely to improve chemotherapy.

摘要

化疗药物是转移性肿瘤最有效的治疗方法。然而,癌细胞同时对不同药物产生耐药性的能力——即所谓的多药耐药性——仍然是成功化疗的重大障碍。三十年来对多药耐药性的研究已经确定了癌细胞逃避化疗的多种方式,而且很明显,每种有效药物甚至是最新的药物都存在耐药性。因此,预测和规避耐药性的能力可能会改善化疗效果。

相似文献

1
Multidrug resistance in cancer: role of ATP-dependent transporters.癌症中的多药耐药性:ATP 依赖性转运蛋白的作用
Nat Rev Cancer. 2002 Jan;2(1):48-58. doi: 10.1038/nrc706.
2
[Drug distribution, resistance to cytostatics and disease pathogenesis: many roles of ABC proteins].[药物分布、对细胞抑制剂的耐药性与疾病发病机制:ABC蛋白的多种作用]
Lakartidningen. 2004 Jan 22;101(4):282-7.
3
Modulation of multidrug resistance efflux pump activity to overcome chemoresistance in cancer.调节多药耐药外排泵活性以克服癌症中的化疗耐药性。
Curr Opin Pharmacol. 2006 Aug;6(4):350-4. doi: 10.1016/j.coph.2006.01.009. Epub 2006 May 11.
4
Multidrug resistance.多药耐药性
Cancer Chemother Biol Response Modif. 1999;18:152-77.
5
Role of the breast cancer resistance protein (ABCG2) in drug transport.乳腺癌耐药蛋白(ABCG2)在药物转运中的作用。
AAPS J. 2005 May 11;7(1):E118-33. doi: 10.1208/aapsj070112.
6
Drug resistance molecules: lessons from oncology.耐药分子:肿瘤学的经验教训
Novartis Found Symp. 2002;243:19-31; discussion 31-7, 180-5.
7
[Drug resistance mediated by ABC transporters].[ABC转运蛋白介导的耐药性]
Gan To Kagaku Ryoho. 2004 Jan;31(1):1-6.
8
Multidrug resistance.多重耐药性
Cancer Chemother Biol Response Modif. 1997;17:139-77.
9
Multidrug resistance proteins: role of P-glycoprotein, MRP1, MRP2, and BCRP (ABCG2) in tissue defense.多药耐药蛋白:P-糖蛋白、多药耐药相关蛋白1、多药耐药相关蛋白2和乳腺癌耐药蛋白(ABCG2)在组织防御中的作用
Toxicol Appl Pharmacol. 2005 May 1;204(3):216-37. doi: 10.1016/j.taap.2004.10.012.
10
Mouse ATP-Binding Cassette (ABC) Transporters Conferring Multi-Drug Resistance.赋予多药耐药性的小鼠ATP结合盒(ABC)转运蛋白
Anticancer Agents Med Chem. 2015;15(4):423-32.

引用本文的文献

1
L.: Analysis of Chemical Profile and Cytotoxic Action on Tumor (HeLa) and Non-Tumor Cells (NIH/3T3).L.:肿瘤(HeLa)和非肿瘤细胞(NIH/3T3)的化学特征分析及细胞毒性作用
Pharmaceuticals (Basel). 2025 Aug 14;18(8):1199. doi: 10.3390/ph18081199.
2
Urinary exosomal RAB11A serves as a novel non-invasive biomarker for diagnosis, treatment response monitoring, and prognosis in small cell lung cancer.尿外泌体RAB11A作为一种新型非侵入性生物标志物,用于小细胞肺癌的诊断、治疗反应监测及预后评估。
Clin Proteomics. 2025 Aug 25;22(1):30. doi: 10.1186/s12014-025-09554-4.
3
ABCC1 promotes GSH-dependent iron transport and resistance to Fe(II) and Cu(II) chelators.
ABCC1促进谷胱甘肽依赖的铁转运以及对亚铁离子和铜离子螯合剂的抗性。
Biometals. 2025 Aug 25. doi: 10.1007/s10534-025-00736-z.
4
Emerging trends and global collaboration in Paclitaxel resistance research for breast cancer: a comprehensive bibliometric study.乳腺癌紫杉醇耐药性研究的新趋势与全球合作:一项全面的文献计量学研究
Discov Oncol. 2025 Aug 24;16(1):1602. doi: 10.1007/s12672-025-03420-3.
5
GPT2 mediates glutamine metabolism-driven metabolic alterations in platinum-resistant ovarian cancer cells.GPT2介导铂耐药卵巢癌细胞中谷氨酰胺代谢驱动的代谢改变。
Sci Rep. 2025 Aug 20;15(1):30528. doi: 10.1038/s41598-025-15707-0.
6
ERα36 Promotes -Mediated Adriamycin Resistance via Non-Genomic Signaling in Triple-Negative Breast Cancer.雌激素受体α36通过非基因组信号通路促进三阴性乳腺癌中的阿霉素耐药性。
Int J Mol Sci. 2025 Jul 25;26(15):7200. doi: 10.3390/ijms26157200.
7
NF-κB signaling pathway in osteosarcoma: from signaling networks to targeted therapy.骨肉瘤中的核因子κB信号通路:从信号网络到靶向治疗
Front Oncol. 2025 Jul 25;15:1565760. doi: 10.3389/fonc.2025.1565760. eCollection 2025.
8
Recent advances in cell membrane-based biomimetic delivery systems for Parkinson's disease: Perspectives and challenges.基于细胞膜的帕金森病仿生递送系统的最新进展:前景与挑战
Asian J Pharm Sci. 2025 Aug;20(4):101060. doi: 10.1016/j.ajps.2025.101060. Epub 2025 Apr 21.
9
Influence of OCT2 gene variants on metformin efficacy in type 2 diabetes: insights into pharmacogenomics and drug interactions.OCT2基因变异对2型糖尿病患者二甲双胍疗效的影响:药物基因组学与药物相互作用的见解
J Transl Med. 2025 Aug 7;23(1):884. doi: 10.1186/s12967-025-06720-y.
10
Exploring the interplay between LDHA and ABCC1 in breast cancer using computational approach.利用计算方法探索乳腺癌中LDHA与ABCC1之间的相互作用。
Discov Oncol. 2025 Aug 5;16(1):1471. doi: 10.1007/s12672-025-03354-w.